Larissa J. Maier

1.5k total citations
61 papers, 1.0k citations indexed

About

Larissa J. Maier is a scholar working on Epidemiology, Clinical Psychology and Pharmacology. According to data from OpenAlex, Larissa J. Maier has authored 61 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 13 papers in Clinical Psychology and 10 papers in Pharmacology. Recurrent topics in Larissa J. Maier's work include Substance Abuse Treatment and Outcomes (9 papers), Neuroethics, Human Enhancement, Biomedical Innovations (8 papers) and Attention Deficit Hyperactivity Disorder (7 papers). Larissa J. Maier is often cited by papers focused on Substance Abuse Treatment and Outcomes (9 papers), Neuroethics, Human Enhancement, Biomedical Innovations (8 papers) and Attention Deficit Hyperactivity Disorder (7 papers). Larissa J. Maier collaborates with scholars based in Switzerland, United Kingdom and Australia. Larissa J. Maier's co-authors include Michael P Schaub, Adam Winstock, Jason Ferris, Matthias E. Liechti, Monica J. Barratt, E. Werle, Renee Zahnow, Emma Davies, Severin Haug and Joseph J. Palamar and has published in prestigious journals such as PLoS ONE, Psychopharmacology and Addiction.

In The Last Decade

Larissa J. Maier

57 papers receiving 937 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Larissa J. Maier Switzerland	18	324	285	192	183	179	61	1.0k
Cynthia Forlini Australia	19	542 1.7×	182 0.6×	207 1.1×	81 0.4×	75 0.4×	45	944
Stefan Gutwinski Germany	18	226 0.7×	321 1.1×	138 0.7×	66 0.4×	152 0.8×	75	1.1k
Amine Benyamina France	17	97 0.3×	322 1.1×	141 0.7×	287 1.6×	204 1.1×	48	964
Raina D. Pang United States	23	152 0.5×	309 1.1×	56 0.3×	118 0.6×	123 0.7×	86	1.4k
Carl Roberts United Kingdom	17	170 0.5×	304 1.1×	90 0.5×	208 1.1×	73 0.4×	55	899
Fermín Fernández‐Calderón Spain	17	93 0.3×	343 1.2×	207 1.1×	126 0.7×	326 1.8×	80	883
Kirstin M. Gatchalian United States	17	325 1.0×	235 0.8×	101 0.5×	55 0.3×	180 1.0×	19	1.3k
Gerald F.X. Feeney Australia	21	97 0.3×	453 1.6×	382 2.0×	91 0.5×	450 2.5×	74	1.3k
Mark L. Rubinstein United States	25	91 0.3×	220 0.8×	58 0.3×	129 0.7×	138 0.8×	42	1.7k
Megan Weier Australia	16	132 0.4×	265 0.9×	136 0.7×	744 4.1×	380 2.1×	36	1.5k

Countries citing papers authored by Larissa J. Maier

Since Specialization

Citations

This map shows the geographic impact of Larissa J. Maier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larissa J. Maier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larissa J. Maier more than expected).

Fields of papers citing papers by Larissa J. Maier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larissa J. Maier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larissa J. Maier. The network helps show where Larissa J. Maier may publish in the future.

Co-authorship network of co-authors of Larissa J. Maier

This figure shows the co-authorship network connecting the top 25 collaborators of Larissa J. Maier. A scholar is included among the top collaborators of Larissa J. Maier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larissa J. Maier. Larissa J. Maier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Anderson, B., Ann Berger, Roland R. Griffiths, et al.. (2023). Psychedelic Science, Contemplative Practices, and Indigenous and Other Traditional Knowledge Systems: Towards Integrative Community-Based Approaches in Global Health. Journal of Psychoactive Drugs. 55(5). 523–538. 9 indexed citations

Peacock, Amy, Aili Malm, Rasmus Munksgaard, et al.. (2023). The relationship between cryptomarket drug purchase, social networks and adverse drug events: A cross-sectional study. International Journal of Drug Policy. 123. 104258–104258. 2 indexed citations

Connolly, Dean J., Emma Davies, Michael T. Lynskey, et al.. (2022). Differences in Alcohol and Other Drug Use and Dependence Between Transgender and Cisgender Participants from the 2018 Global Drug Survey. LGBT Health. 9(8). 534–542. 15 indexed citations

Davies, Emma, Cheneal Puljević, Gail Gilchrist, et al.. (2021). Impacts of changes in alcohol consumption patterns during the first 2020 COVID-19 restrictions for people with and without mental health and neurodevelopmental conditions: A cross sectional study in 13 countries. International Journal of Drug Policy. 101. 103563–103563. 10 indexed citations

Maier, Larissa J., Danielle E. Ramo, Manpreet Kaur, Meredith C. Meacham, & Derek D. Satre. (2020). Factors associated with readiness to quit smoking among young adults enrolled in a Facebook-based tobacco and alcohol intervention study. Addictive Behaviors. 111. 106524–106524. 5 indexed citations

Petranker, Rotem, Thomas Anderson, Larissa J. Maier, et al.. (2020). Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention. Journal of Psychopharmacology. 36(1). 85–96. 36 indexed citations

Meacham, Meredith C., Danielle E. Ramo, Judith J. Prochaska, et al.. (2020). A Facebook intervention to address cigarette smoking and heavy episodic drinking: A pilot randomized controlled trial. Journal of Substance Abuse Treatment. 122. 108211–108211. 12 indexed citations

Barratt, Monica J., et al.. (2020). On‐site drug checking can provide quantitative analysis. Internal Medicine Journal. 50(8). 1022–1023. 1 indexed citations

Connolly, Dean J., Emma Davies, Michael T. Lynskey, et al.. (2020). Comparing intentions to reduce substance use and willingness to seek help among transgender and cisgender participants from the Global Drug Survey. Journal of Substance Abuse Treatment. 112. 86–91. 19 indexed citations

10.

Davies, Emma, Larissa J. Maier, Adam Winstock, & Jason Ferris. (2019). Intention to reduce drinking alcohol and preferred sources of support: An international cross-sectional study. Journal of Substance Abuse Treatment. 99. 80–87. 15 indexed citations

11.

Davies, Emma, John Holmes, Larissa J. Maier, et al.. (2018). THE IMPACT OF ALCOHOL HEALTH WARNING LABELS ON DRINKING BEHAVIOURS: AN INTERNATIONAL SURVEY. Drug and Alcohol Review. 38. 1 indexed citations

12.

Hughes, Caitlin, Monica J. Barratt, Jason Ferris, Larissa J. Maier, & Adam Winstock. (2018). Drug-related police encounters across the globe: How do they compare?. International Journal of Drug Policy. 56. 197–207. 13 indexed citations

13.

Winstock, Adam, et al.. (2018). Global drugs survey 2018.. 1 indexed citations

14.

Winstock, Adam, Larissa J. Maier, Jason Ferris, & Monica J. Barratt. (2017). The Global Drug Survey: how online methods and independence offer alternative perspectives on drug use. Queensland's institutional digital repository (The University of Queensland).

15.

Maier, Larissa J., Severin Haug, & Michael P Schaub. (2015). The importance of stress, self-efficacy, and self-medication for pharmacological neuroenhancement among employees and students. Drug and Alcohol Dependence. 156. 221–227. 27 indexed citations

16.

Maier, Larissa J., Evangelia Liakoni, Jan Schildmann, Michael P Schaub, & Matthias E. Liechti. (2015). Swiss University Students’ Attitudes toward Pharmacological Cognitive Enhancement. PLoS ONE. 10(12). e0144402–e0144402. 29 indexed citations

17.

Maier, Larissa J., Severin Haug, & Michael P Schaub. (2015). Prevalence of and motives for pharmacological neuroenhancement in Switzerland-results from a national internet panel. Addiction. 111(2). 280–295. 22 indexed citations

18.

Maier, Larissa J., Matthias Vonmoos, Markus R. Baumgartner, et al.. (2015). Pharmacological Cognitive Enhancement in Healthy Individuals: A Compensation for Cognitive Deficits or a Question of Personality?. PLoS ONE. 10(6). e0129805–e0129805. 35 indexed citations

19.

Maier, Larissa J., et al.. (1963). [MIMA POLYMORPHA IN A BRAIN ABSCESS IN A WAR-INJURED PERSON].. PubMed. 149. 76–81. 2 indexed citations

20.

Werle, E & Larissa J. Maier. (1952). [Chemical and pharmacologic differentiation of kallikreins of various origins].. PubMed. 323(4). 279–83. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact